Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus
Abstract Use of galectin-3 for assessing cardiac function in prediabetes and type 2 diabetes mellitus (T2DM) needs to be established. Within the Gutenberg Health Study cohort (N = 15,010, 35–74 years) patient characteristics were investigated regarding galectin-3 levels. Prognostic value of galectin...
Saved in:
Main Authors: | Volker H. Schmitt, Jürgen H. Prochaska, Annegret S. Föll, Andreas Schulz, Karsten Keller, Omar Hahad, Thomas Koeck, Sven-Oliver Tröbs, Steffen Rapp, Manfred Beutel, Norbert Pfeiffer, Konstantin Strauch, Karl J. Lackner, Thomas Münzel, Philipp S. Wild |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/1271f9e7354d4fb6bc7fa4de94870c45 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NT-ProBNP levels in saliva and its clinical relevance to heart failure.
by: Jared Yong Yang Foo, et al.
Published: (2012) -
Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
by: Bader Alsuwailem, et al.
Published: (2021) -
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
by: Lidia Staszewsky, et al.
Published: (2021) -
The Ratio of NT-proBNP to CysC1.53 Predicts Heart Failure in Patients With Chronic Kidney Disease
by: Sheng Wang, et al.
Published: (2021) -
Association of NT-proBNP and multiple biomarkers with severity of angiographic coronary artery disease in diabetic and pre-diabetic Chinese patients.
by: Zhou Fang, et al.
Published: (2011)